Hip Fracture Incidence Up With Non-Dialysis-Requiring CKD

This article originally appeared here.
Share this content:
Hip Fracture Incidence Up With Non-Dialysis-Requiring CKD
Hip Fracture Incidence Up With Non-Dialysis-Requiring CKD

FRIDAY, May 27, 2016 (HealthDay News) -- The incidence of hip fracture and post-hip fracture mortality are increased for patients with non-dialysis-requiring chronic kidney disease (CKD), according to a study published online May 4 in the Journal of Bone and Mineral Research.

Sun Moon Kim, from Stanford University in Palo Alto, Calif., and colleagues used data from the Healthcare Cost and Utilization Project's Nationwide Inpatient Sample for patients with hospitalization for hip fracture in 2010 to examine the risk for and consequences of hip fracture among patients with non-dialysis-requiring CKD.

The researchers found that patients with end-stage renal disease had the highest age-standardized incidence of hip fracture (3.89/1,000 persons), followed by non-dialysis-requiring CKD and patients with normal or near normal kidney function (1.81 and 1.18/1,000 persons, respectively). Compared to patients with normal or near normal kidney function, those with non-dialysis-requiring CKD had significantly higher in-hospital mortality (odds ratio, 1.69), length of stay (median, five [90 percent confidence interval, three to 11] versus five [90 percent confidence interval, three to 10] days), and costs (median, $14,807 versus $13,314)

"In summary, non-dialysis-requiring CKD is associated with higher age-standardized rates of hip fracture and post-hip fracture mortality, and higher resource utilization," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »